+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 99Years
All Genders
ID05202210

Biological Sample Collection to Study Noonan Syndrome and Understand Disease Progression

Led by University Hospital, Toulouse · Updated on 2026-03-19

100

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research focuses on Noonan syndrome, a rare genetic disorder affecting multiple body systems including the face, heart, growth, skeleton, and development. The study aims to create a collection of biological samples to better understand the diseases mechanisms and identify factors that predict how the condition progresses over time. Patients with Noonan syndrome or related conditions are followed at Toulouse University Hospital as part of this observational study. During regular medical check-ups, patients will provide extra samples of blood and urine, which will be collected and securely stored for research purposes. These samples will help researchers answer important questions about the disease and support future studies. Participation involves consenting to the collection and use of these biological samples. Participants will be involved during their routine visits, where additional blood and urine samples will be taken. The researchers will maintain confidentiality and use these samples to build a biological collection. The main outcome measure is the establishment of this collection from patients with Noonan syndrome or related disorders. The study runs from January 2022 through January 2032, with no intervention beyond sample collection.

CONDITIONS

Brief Title

Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children aged at least 3 years old or adults with Noonan syndrome
  • Patients affiliated to or beneficiaries of a social security scheme
  • Patients able to receive information on the progress of the study and understand the information form to participate in the study, implying mastery of the French language and no judicial restriction of rights
  • Patients or legal representatives who have given their consent to participate in the study (expression of no objection)
Not Eligible

You will not qualify if you...

  • Patients subject to a legal protection measure such as guardianship, curatorship, or safeguard of justice
  • Pregnant or breastfeeding women

Research Team

T

Thomas EDOUARD, MD, PhD

F

Françoise Auriol, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here